1-4 of 4
Jonathan Sussman, MD FRCPC, MSc
Close
Sort by
Journal Articles

Trajectory of Symptoms after Autologous Stem Cell Transplant Among Patients with Multiple Myeloma: A Population-Based Study

Hira S Mian, MD, Gregory R Pond, PhD PStat, Tanya M. Wildes, MD MSCI, Branavan Sivapathasundaram, MSc, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-133869
Published: 2020
Journal Articles

Symptom Burden in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Population-Based Study of Patient-Reported Outcomes

Hira S Mian, MD, Gregory R Pond, PhD PStat, Branavan Sivapathasundaram, MSc, Tanya M. Wildes, MD MSCI, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-133369
Published: 2020
Journal Articles

Undertreatment of Older Patients with Newly-Diagnosed Multiple Myeloma: Real World Evidence from a Canadian Registry Cohort

Hira S Mian, MD, C. Tom Kouroukis, MDMSc,FRCPC, Gregory R Pond, PhD PStat, Hsien Seow, PhD, Jonathan Sussman, MD FRCPC, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 268.
https://doi.org/10.1182/blood-2019-121672
Published: 2019
Journal Articles

Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial

Laura N Rodriguez-Romo, MD, Ralph Meyer, MDFRCPC, Joseph L Pater, MD, Jonathan Sussman, MD FRCPC, MSc, Siwei Zhang, MSc, Lui Hongbo, MSc, PhD, Jane N. Winter, MD, Te Vuong, MD, Walter Blahey, MD, Liam Mulroy, MD, Lois E. Shepherd, Marina S Djurfeldt, MSc, Bingshu E. Chen, Annette E Hay
Journal: Blood
Blood (2017) 130 (Supplement 1): 4081.
https://doi.org/10.1182/blood.V130.Suppl_1.4081.4081
Published: 2017